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Plasma membrane microcompartments could allow different
signaling pathways to operate more efficiently and prevent
cross-talk. We utilized a novel in-cell biotin transfer assay to
demonstrate that the majority of plasma membrane-expressed
D2 dopamine receptor (D2R) is microcompartmentalized
within detergent-resistant structures. Conversely, a minority of
D2R existed in a detergent-soluble form and interacted in a relatively unrestricted manner with other cellular proteins. The
microcompartmentalization of D2R had functional consequences because dopamine-induced internalization of D2R was
largely restricted to the compartmentalized receptor. The D2Rcontaining microcompartments did not correspond to putative
detergent-resistant lipid raft structures. First, the detergent-insoluble D2R structures were significantly denser than detergent-resistant membrane fragments containing flotillin, a
widely utilized lipid raft marker protein. Second, the detergent
solubility of D2R was unaffected by treatment of cells with the
cholesterol chelating agent, methyl-␤-cyclodextrin, that is
thought to disrupt lipid rafts. Finally, the in-cell biotinylation
assay did not provide any evidence for the membrane compartmentalization of peptide motifs thought to target to lipid rafts.
Thus, our observations form one of the first demonstrations, in
living cells, of plasma membrane microcompartments defined
by the ability of the compartment structure to broadly restrict
the interaction of resident molecules with other cellular
proteins.

According to the fluid mosaic model, biological membranes
can be considered as a two-dimensional fluid along which lipids
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and associated proteins are free to diffuse and interact with
each other (1). However, the specificity of many membraneassociated biochemical reactions and the ability of cells to distinguish between the numerous signals transmitted across the
membrane have led to suggestions that many proteins are
microcompartmentalized in the membrane, although they
appear to be uniformly distributed when examined using
microscopic techniques (2, 3). Nevertheless, 4 decades after the
proposal of the fluid mosaic model by Singer and Nicolson (1),
definitive proof of such plasma membrane microcompartments that exist in living cells to restrict non-resident components from interacting with resident molecules has not been
presented.
Studies of model membranes indicated that rafts of cholesterol and certain lipid molecules (e.g. sphingolipids) could create less fluid areas within lipid membranes. Subsequently,
buoyant detergent-resistant aggregations enriched in cholesterol, sphingolipids, and distinctive proteins were isolated after
detergent solubilization of cellular material. These findings
gave rise to the idea that such aggregations originated from lipid
raft complexes that existed in living cells and functioned as
membrane compartments that could include certain proteins
and exclude others (4 – 6). However, no definitive evidence has
been provided to show that detergent-resistant biochemical
fractions necessarily originate from microdomains that existed
in intact cells before detergent was added or for the existence of
canonically defined lipid rafts in living cells (7–12). Detergent
treatment alters the properties of both lipids and proteins, and
it has been shown that aggregation or segregation of membrane
components can occur as an artifact of detergent treatment (13,
14).
Evidence exists for small transient clusters of cholesterol,
sphingolipids, and membrane proteins (3, 7, 11) and for the
transient restriction of some proteins to submicroscopic
regions of the plasma membrane (15). However, clustering and
compartmentalization are distinct phenomena, and the biological relevance of these processes has been questioned because
their half-lives are shorter than that of most protein-protein
interactions (11).
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Background: Plasma membrane microcompartmentalization could provide multiple unique environments for the operation of different signaling pathways.
Results: An in-cell biotin transfer assay showed highly restricted cellular accessibility for a detergent-resistant but functional
pool of plasma membrane-expressed D2 dopamine receptor (D2R).
Conclusion: D2R is segregated in special plasma membrane microcompartments.
Significance: Our data provide one of the first definitive demonstrations of plasma membrane microcompartmentalization in
living cells.

Plasma Membrane Compartmentalization of D2 Dopamine Receptors

MATERIALS AND METHODS
Chemicals—All chemicals and reagents were purchased from
Sigma-Aldrich or Thermo Fisher Scientific or from suppliers
specifically identified below.
Cell Culture—HEK293T cells (American Type Culture Collection, Manassas, VA) were maintained and transfected in
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal
bovine serum (Sigma) supplemented with penicillin and streptomycin. The cells were grown at 37 °C and 5% CO2. Transfection of cells was carried out using Lipofectamine LTX (Invitrogen) according to the manufacturer’s instructions. Total
transfected DNA was kept constant between groups using
pcDNA3.1/Zeo(⫹) (Invitrogen) mammalian expression vector.

3

The abbreviations used are: D2R, D2 dopamine receptor long isoform; Arr,
arrestin3; AP, acceptor peptide substrate for the biotin ligase enzyme with
amino acid sequence of GLNDIFEAQKIEWHE; BirA, E. coli biotin ligase; BL,
biotin ligase enzyme; D2R-AP3rd-loop, D2 dopamine receptor long isoform
fused to the AP substrate for the BL enzyme to the third cytoplasmic loop;
D2R-APC-tail, D2 dopamine receptor long isoform fused to the AP substrate
tethered to the cytoplasmic C-tail of D2R; EZ-Link sulfo-NHS-LC-biotin, sulfosuccinimidyl 6-(biotinamido) hexanoate; FLAG, octapeptide with amino
acid sequence of DYKDDDDK; HA tag, a peptide with amino acid sequence
YPYDVPDYA from human influenza HA; HEK293T, human embryonic kidney 293 cells stably expressing the SV40 T-antigen; KRAS-BL, KRAS-derived
plasma membrane-targeting motif-biotin ligase protein fusion construct;
LCK-BL, LCK kinase-derived plasma-membrane targeting motif-biotin
ligase protein fusion construct; LYN-BL, LYN kinase-derived plasma-membrane targeting motif-biotin ligase protein fusion construct; M␤CD, methyl-␤-cyclodextrin; MOR, -opioid receptor; NM, neuromodulin-derived
plasma membrane-targeting motif; TX100, Triton X-100; V5 tag, a peptide
with amino acid sequence of GKPIPNPLLGLDST; ANOVA, analysis of variance; RBE, relative biotinylation efficacy.
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FIGURE 1. Schematic representation (N- to C-terminal) of the complementary fusion proteins containing the AP substrate for BirA (A) and the BirA
enzyme (B) that were utilized in this study. A, the numbers 305 and 306 in
the top panel refer to the position of the residues in the third cytoplasmic loop
of D2R between which the AP substrate was inserted. The squiggly line connecting the AP substrate to D2R in the center panel represents a flexible 106amino acid linker from the constant region of the human immunoglobulin
1-light-chain constant region. B, in the bottom panel, the numbers represent
the amino acid residues in the G␣i1 between which the V5 tag and the BirA
enzyme were inserted.

cDNA Constructs—The cDNAs for the constructs described
below were assembled using standard molecular biology protocols. All of the constructs, except for the neuromodulin/
GAP-43 (NM)-AP fusion substrate, were cloned into the mammalian expression vector pcDNA3.1/Zeo(⫹) (Invitrogen). The
cDNA for NM-AP was inserted into the pJ602 mammalian
expression vector (DNA 2.0). Schematics of the various protein
constructs used in this study are shown in Fig. 1.
The cDNA for the FLAG-tagged D2R and -opioid receptor
(MOR) constructs have been previously described and consist
JOURNAL OF BIOLOGICAL CHEMISTRY
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The D2 dopamine receptor (D2R)3 is a clinically important G
protein-coupled receptor because it is a major target of drugs
used to alleviate symptoms of Parkinson disease and depression
(16, 17). In addition, a common property of all currently available antipsychotic drugs is that they block D2R at therapeutic
concentrations (18).
We previously showed that the vast majority of D2R
expressed in the brain is uniquely resistant to detergent solubilization (19) and wanted to explore the biological significance of
our observation. We utilized a novel in-cell biotin transfer assay
involving the Escherichia coli biotin ligase enzyme, BirA, that
specifically attaches biotin to a unique acceptor peptide (AP)
(20). We 1) attached AP to D2R, 2) fused the biotin ligase
enzyme to a wide variety of cellular proteins, and 3) in a series of
experiments, introduced the D2R-AP target and a biotin ligase
enzyme-fusion into living cells. After the cells were solubilized
in detergent we found that, in almost every case, the biotinylation of the detergent-resistant form of D2R-AP substrate was
barely detectable. Instead, most of the biotin was found
attached to the detergent-soluble D2R-AP, which formed less
than 25% of the total cellular D2R-AP. However, we showed
that the detergent-resistant forms of both D2R and the D2R-AP
fusion were functional and could respond to dopamine. The
results from the above experiments provide the first clear demonstration, in living cells, of two functional populations of a
plasma membrane protein that differ broadly in their level of
compartmentalization from other cellular proteins.
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The arrestin3-biotin ligase fusion (Arr-BL) consisted of the
following fused peptide sequences, in order, from the N to the C
terminus: bovine arrestin3 (GenBankTM accession number
NP_001192206), the GSGSG linker, and BirA. The D2R-biotin
ligase fusion (D2R-BL) was constructed by tethering BirA,
tagged at the N terminus with the V5 epitope tag, to the C-tail of
the FLAG epitope-tagged D2R construct described above. The
biotin ligase construct, BL, consisted of the E. coli biotin ligase,
BirA, tagged at the C terminus with the V5 epitope.
The G protein-biotin ligase fusion (G␣i-BL) was constructed
by inserting BirA tagged at the N terminus with the V5 epitope
between positions 91 and 92 (amino acids Leu and Lys, respectively) of the pertussis toxin-insensitive C351G mutant of
human G␣i1 (GenBankTM accession number P63096). The
V5-tagged BirA enzyme was inserted into an internal position
within the primary sequence of G␣i1 and not into the N or C
terminus because the G protein G␣ N-terminal region is important for association with the G protein G␤␥ dimer, and the
C-terminal region is required for interaction with receptors.
Therefore, the V5 epitope-tagged BirA enzyme was inserted
into a loop within ␣-helical domain of the G␣i1 subunit. Insertion of various sequences into G␣ subunits at this position has
been previously shown to allow the G␣ subunits to retain
important functions, such as activation by receptors and the
modulation of important effectors (23, 24). The PCR and cloning steps utilized in the construction of this fusion resulted in
the introduction of the peptide sequences GGSLTTM and
GSGSGDI, flanking the N and C terminus of the V5-BirA insertion, respectively. Thus, the G␣i-BL fusion construct consisted
of the following fused peptide sequences in order from the N to
the C terminus: G␣i1 fragment 1–91, the peptide sequence
GGSLTTM, the V5 epitope tag, BirA, the peptide sequence
GSGSGDI, and the G␣i1 C351G mutant fragment 92–353.
Cell Surface Biotinylation—HEK293T cells were transiently
transfected with cDNA for either the extracellular N-terminal
FLAG-tagged D2Rs, the D2R-APC-tail construct (tagged at the
C terminus with the HA epitope tag), or the N-terminal FLAGtagged MORs in a 6-well plate (4 ⫻ 105 cells/well) and cultured
for 48 h to allow for transient expression of the respective protein constructs. Proteins expressed specifically at the surface of
the cultured cells were biotinylated using EZ-Link Sulfo-NHSLC-Biotin (Thermo Fisher Scientific, Pierce), a membrane-impermeable biotinylation reagent that reacts with primary
amines of peptides projecting out into the extracellular space
(25, 26). The cells were treated with the biotinylation reagent at
a concentration of 1 mg/ml for 30 min at 4 °C according to the
manufacturer’s instructions. After the biotinylation reaction
had occurred, the cells were washed three times in phosphatebuffered solution (PBS; 137 mM NaCl, 2.7 mM KCl, 10
Na2HPO4, 2 mM KH2PO4, pH 7.4) containing glycine (100 mM)
at 4 °C to remove and quench excess biotinylation reagent. The
cells were then lysed in PBS (500 l/well) containing 2% (v/v) of
the non-ionic detergent, Triton X-100 (TX100), and a protease
inhibitor mixture (SIGMAFASTTM protease inhibitor mixture
tablets with EDTA, Sigma-Aldrich) for 1 h at 4 °C. The cell
lysates in each well were then separately centrifuged at
10,000 ⫻ g for 10 min at 4 °C to sediment the TX100-insoluble
(pellet) cellular fraction, and the TX100-insoluble pellet was
VOLUME 288 • NUMBER 18 • MAY 3, 2013
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of the FLAG epitope tag attached to the extracellular N terminus of the human D2R (long form) and mouse MOR, respectively (21).
The cDNA for the fusions of D2R with an attenuated AP
substrate sequence (GLNDIFEAQKIE) (20) for the E. coli biotin
ligase, BirA, contained the FLAG epitope tag at the extracellular
N terminus. D2R-AP3rd-loop fusion was constructed by inserting the AP sequence between positions 305 and 306 (amino
acids Leu and Thr) in the third cytoplasmic loop of FLAGtagged human D2R long form. The D2R-APC-tail fusion was
constructed by tethering AP to the cytoplasmic C-tail of the
FLAG-tagged D2R construct via a flexible 106-amino acid
linker corresponding to the constant region (amino acids 131–
236; see GenBankTM entry AAD29608.1) of the human immunoglobulin 1-light-chain constant region (IgC). The D2RAPC-tail also contained an HA epitope tag (YPYDVPDYA) at the
C terminus. Thus, the D2R-APC-tail construct consisted of the
following fused peptide sequences, in order, from the N to the C
terminus: FLAG epitope-tagged human D2R long form, IgC,
AP substrate sequence (GLNDIFEAQKIE), and HA epitope tag.
NM-AP consisted of the following fused peptide sequences,
in order, from the N to the C terminus: the membrane-targeting peptide sequence (MLCCMRRTKQVEKNDEDQKI) from
NM (22), a 7-amino acid (GSGGGSG) flexible linker, the AP
substrate, and the GSGGGSG linker followed by the HA
epitope tag.
The cDNA for the E. coli biotin ligase, BirA (20), was provided by Dr. Alice Ting (Massachusetts Institute of Technology) and was amplified by standard PCR for use in the construction of the BirA-containing fusions. The BirA fusions used to
biotinylate the AP substrate-containing constructs were composed of the following sequences and were inserted in the
pcDNA3.1/Zeo(⫹) vector. The neuromodulin-biotin ligase
fusion, NM-BL, consisted of a membrane-targeting peptide
sequence from NM, fused to the N terminus of the E. coli biotin
ligase, BirA, via a 5-amino acid flexible linker (GSGSG). The
fusion was labeled at the C terminus with the V5 epitope tag,
GKPIPNPLLGLDST. Thus, the NM-BL fusion construct consisted of the following fused peptide sequences, in order, from
the N to the C terminus: the NM membrane-targeting peptide,
the GSGSG linker, BirA, and the V5 epitope tag. The LYN
kinase-biotin ligase fusion (LYN-BL) consisted of the following
fused peptide sequences, in order, from the N to the C terminus: a membrane-targeting peptide sequence (MGCIKSKRKDNLNDDE) from LYN kinase, the GSGSG linker, BirA,
and the V5 epitope tag. The LCK-biotin ligase fusion (LCK-BL)
consisted of the following fused peptide sequences, in order,
from the N to the C terminus: a membrane-targeting peptide
sequence (MGCGCSSHPE) from the kinase, LCK, the GSGSG
linker, BirA, and the V5 epitope tag. The KRAS-biotin ligase
fusion (KRAS-BL) consisted of the following fused peptide
sequences, in order from the N to the C terminus: the V5
epitope tag, BirA, the GSGSG linker, and a membrane-targeting peptide sequence (KKKKKKSKTKCVIM) from KRAS.
Note that the membrane-targeting sequence from KRAS is
present at the C terminus of the endogenous KRAS protein, and
hence this membrane targeting sequence was attached to the
very C terminus of the fusion protein.
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probing Western blots of these samples with horseradish peroxidase (HRP)-conjugated streptavidin.
Estimation of the Relative Buoyancies of TX100-insoluble
D2R-containing and Flotillin-containing Cellular Membrane in
Sucrose Solutions—1 ⫻ 106 HEK293T cells were plated per well
of a 6-well cell culture plate and transiently transfected with
cDNA for the FLAG-tagged D2R construct. 48 h post-transfection, the cells from 2 wells of the plate were combined and lysed
in TNE lysis buffer (25 mM Tris-HCl, 150 mM NaCl, 5 mM
EDTA, SIGMAFAST protease inhibitor mixture, 2% (v/v)
TX100, pH 7.5) for 1 h at 4 °C. The cell lysates were centrifuged
at 10,000 ⫻ g for 10 min at 4 °C to pellet the TX100-insoluble
fractions. The TX100-insoluble pellet was then resuspended by
sonication with a probe sonicator (XL-2000, Qsonica LLC;
three pulses of 0.5 s at power setting 4) in 700 l of the TNE lysis
buffer. 100-l volumes of the resuspended TX100-insoluble
cellular membranes were then layered onto separate solutions
of TNE buffer (25 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA,
SIGMAFAST protease inhibitor mixture, pH 7.5) containing
sucrose at concentrations (w/v) of 30, 40, 50, 60, 70, 80, and
90%, respectively, and centrifuged at 10,000 ⫻ g for 1 h at 4 °C.
The proteins in the TX100-insoluble membranes that were pelleted in each tube were dissolved in 100 l of SDS-urea sample
buffer. The proteins in the TX100-insoluble membrane that
remained buoyant in the supernatant were precipitated by the
addition of trichloroacetic acid (TCA; final concentration of
10% (w/v)), washed three times with cold (4 °C) acetone and,
air-dried and dissolved in 100 l of SDS-urea sample buffer.
Equal volumes of the protein-SDS-urea sample buffer solutions
were resolved by SDS-PAGE, and the relative levels of transiently expressed D2R and endogenously expressed flotillin that
either remained buoyant or sank to the bottom (pellet fraction)
of each of the sucrose cushions were determined as described
under “Western Blotting and Quantification of Protein Signals.” FLAG-tagged D2R was detected on the blots using the
M2 anti-FLAG tag mouse monoclonal antibody (Sigma-Aldrich). Flotillin was detected using anti-flotillin 1 rabbit polyclonal antibody (Sigma-Aldrich).
Methyl-␤-cyclodextrin (M␤CD) Treatment—HEK293T cells
were transiently transfected with cDNA for the HA epitopetagged D2R-APC-tail. 48 h post-transfection, the cell culture
medium was replaced with serum-free DMEM, and the cells
were treated in the serum-free DMEM with 10 mM sterile filtered M␤CD (Acros Organics) for 1 h at 37 °C. The cell surface
proteins were specifically biotinylated using the membrane-impermeable EZ-Link Sulfo-NHS-LC-Biotin reagent, and then
the biotinylated TX100-soluble and -insoluble proteins were
separated, isolated, resolved on SDS-PAGE, and Western blotted as described under “Cell Surface Biotinylation.” The relative
levels of transiently expressed D2R and endogenously
expressed flotillin that segregated into the TX100-soluble and
-insoluble plasma membrane fractions from cells treated with
either M␤CD or vehicle were determined as described under
“Western Blotting and Quantification of Protein Signals.”
FLAG-tagged D2R was detected on the blots using the M2 antiFLAG tag mouse monoclonal antibody (Sigma-Aldrich), and
the HA epitope-tagged D2R-APC-tail construct was detected
using the HA.11 anti-HA tag mouse monoclonal antibody
JOURNAL OF BIOLOGICAL CHEMISTRY
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resuspended in 100 l of 2% SDS-containing buffer (2% (w/v)
SDS, 10 mM EDTA, 50 mM Tris-HCl, SIGMAFASTTM protease
inhibitor mixture, pH 7.5). Both the TX100-soluble fraction
(supernatant from the centrifugation) and the TX100-insoluble
fraction that was resuspended in SDS buffer were incubated at
65 °C for 15 min. Subsequently, dilution buffer (6 mM EDTA,
2% (v/v) TX100, SIGMAFASTTM protease inhibitor mixture)
was added to the TX100-insoluble fraction to reduce the SDS
concentration to 0.2% (w/v). Dilution buffer was also added to
the solution containing the TX100-soluble fraction (supernatant from centrifugation) so as to equalize the volume with the
solution containing the TX100-insoluble cellular fraction, and
both sets of solutions were cooled on ice. The biotinylated cell
surface proteins were then extracted from the respective solutions using streptavidin-agarose resin (Thermo Fisher Scientific, Pierce). 50 l of the resin, previously washed three times
with wash buffer (150 mM NaCl, 6 mM EDTA, 50 mM Tris-HCl,
0.1% (v/v) TX100, pH 7.5), was added to each of the solutions
and incubated at 4 °C with shaking for 1 h. The agarose resin
was separated by centrifugation (8000 ⫻ g for 1 min) and then
washed three times in wash buffer. The protein bound to each
of the resin aliquots was eluted into 50 l of SDS sample buffer
(2% (w/v) SDS, 50 mM Tris-HCl, 50 mM DTT, 0.1% (w/v) bromphenol blue, pH 6.8) by incubating in a boiling water bath for
10 min. Equal volumes of the extracted protein-SDS sample
buffer solutions were subjected to SDS-PAGE, and the resolved
proteins were transferred to methanol-wetted polyvinylidene
fluoride (PVDF) membranes by Western blotting. The relative
amounts of the D2R and MOR constructs that segregated into
the TX100-soluble and -insoluble plasma membrane fractions
were determined as described under “Western Blotting and
Quantification of Protein Signals.” FLAG-tagged D2R and
MOR were detected on the blots using the M2 anti-FLAG tag
mouse monoclonal antibody (Sigma-Aldrich), and the HA
epitope-tagged D2R-APC-tail construct was detected using the
HA.11 anti-HA tag mouse monoclonal antibody (Covance).
The native D2R was detected using a polyclonal rabbit antibody
(TH-50, Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Receptor Internalization Assay—HEK293T cells were transiently transfected with cDNA for either the extracellular
N-terminal FLAG-tagged D2R or the HA epitope-tagged D2RAPC-tail. Approximately 48 h post-transfection, cells were
treated with dopamine (10 M from a stock of 10 mM dopamine
that contained 5 mM ascorbic acid to inhibit dopamine oxidation) for 30 min and then were washed three times with ice-cold
PBS to stop further receptor trafficking. The amount of D2R
remaining at the cell surface was estimated relative to control
D2R-expressing cells that were treated with vehicle, utilizing
the protocol described under “Cell Surface Biotinylation.”
Briefly, the cell surface proteins were specifically biotinylated
with membrane-impermeable EZ-Link Sulfo-NHS-LC-Biotin
reagent and then lysed in TX100. The amounts of biotinylated
D2R that segregated into either the TX100-soluble or -insoluble fractions of dopamine-treated cells was estimated relative to
the corresponding D2R signal from cells that were treated only
with vehicle. We confirmed that the total amount of biotinylated protein that could be detected in the TX100-soluble and
insoluble fractions was not altered by dopamine treatment by
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medium described above. After ⬃24 h, they were transiently
co-transfected with cDNA for D2R-AP3rd-loop substrate and a
biotin ligase fusion. Approximately 48 h post-transfection, the
cells were washed twice with PBS at 20 °C and then incubated
for 5 min at 37 °C with PBS containing 10 M biotin and washed
again with cold (4 °C) PBS to remove biotin. After biotin treatment, the cells were fixed with 4% formaldehyde (Polysciences,
Inc.) in PBS for 15 min at 20 °C, washed three times in PBS at
20 °C, and made permeable by treatment with 0.1% (v/v) TX100
in PBS for 5 min at 20 °C. The samples were washed with PBS
(three times at 20 °C), and nonspecific protein binding sites
were blocked by incubation with 3% (w/v) bovine serum
albumin (BSA) in PBS (BSA-PBS) for 1 h at 20 °C. The D2RAP3rd-loop protein was fluorescently labeled by incubating the
cells with a primary mouse monoclonal antibody directed
against the extracellular N-terminal FLAG epitope (M2, SigmaAldrich; 1:500 dilution in PBS containing 3% (w/v) BSA, 1 h at
20 °C). The cells were washed three times at 20 °C in PBS containing 0.5% (v/v) of the detergent Tween 20. After washing, the
cells were incubated (1 h, 20 °C) with BSA-PBS containing
Alexa Fluor 594-conjugated goat anti-mouse secondary antibody (Invitrogen; 1:500 dilution) directed against the antiFLAG mouse monoclonal and Alexa Fluor 488-conjugated
streptavidin (Invitrogen; 1:500 dilution) so as to simultaneously
label the D2R-AP3rd-loop protein and the biotinylated D2RAP3rd-loop, respectively, with fluorescent tags.
The subcellular localization of all the co-expressed biotin
ligase fusions, except for Arr-BL, was determined in a separate
set of cells by using a primary mouse monoclonal antibody
directed against the V5 epitope tag (Invitrogen; 1:1000 dilution)
and an Alexa Fluor 488-conjugated goat anti-mouse secondary
(Invitrogen; 1:500 dilution). The cells were fixed, made permeable, and stained with the primary and secondary antibodies as
described above.
The Arr-BL fusion did not contain a convenient epitope tag.
Therefore, to specifically visualize the subcellular localization
of arrestin when it was co-expressed with D2R-AP3rd-loop,
we utilized an arrestin construct, Arr-YFP, in which arrestin
was fused to enhanced YFP. HEK293T cells were co-transfected
with cDNA for D2R-AP3rd-loop substrate and Arr-YFP, fixed
using formaldehyde, and then mounted on slides as described above for direct visualization of the fluorescence-enhanced YFP tag by confocal laser microscopy.
All images were obtained using an LSM 5 Pascal laser-scanning confocal microscope (Zeiss), ⫻63 oil immersion objective.
Alexa Fluor 488 and enhanced YFP were excited with the
488-nm line from an argon laser, and Alexa Fluor 594 was
excited with the 543-nm line from a helium-neon laser. The
signals from the two fluorophores were separated using appropriate emission filters, and the images were created at a resolution of 1024 ⫻ 1024 pixels using a pixel dwell time of 1.6 s. We
ensured that there was no “bleed-through” of signal from one
fluorophore into the collection window of the other in the double-labeling experiments by imaging cells labeled with only one
of the pair of fluorophores. In these control experiments, no
bleed-through was observed even as the laser power was
increased 200% over that used to collect the images of the double-labeled samples (i.e. cells stained with the anti-FLAG
VOLUME 288 • NUMBER 18 • MAY 3, 2013
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(Covance). Flotillin was detected using anti-flotillin 1 rabbit
polyclonal antibody (Sigma-Aldrich).
Biotinylation of D2R-AP and NM-AP Fusions in TX100-soluble and -insoluble Fractions by Fusions Containing the E. coli
Biotin Ligase, BirA—HEK293T cells cultured in biotin-depleted media (2 ⫻ 105 cells/well of 12-well plates, plated 24 h
before transfection) were transiently co-transfected with
cDNAs for one of the AP substrate-containing fusions, D2RAP3rd-loop or D2R-APC-tail or NM-AP, and a complementary
biotin ligase fusion. Biotin-free medium was prepared by incubating the complete medium (i.e. supplemented with fetal
bovine serum, glutamine, and antibiotics) for 30 min at 20 °C
with 30 l/ml high capacity streptavidin-agarose resin
(Thermo Fisher Scientific, Pierce; the agarose resin was prewashed three times with PBS) and filtered using 2-m pore size
nylon syringe filters (Thermo Fisher Scientific). Approximately
48 h post-transfection, the cells were washed twice with PBS at
20 °C and then incubated for 5 min at 37 °C with PBS containing
10 M biotin and washed again with cold (4 °C) PBS to remove
biotin. In the next step, the cells were lysed in PBS (200 l/well)
containing 2% (v/v) TX100 and SIGMAFAST protease inhibitor mixture for 1 h at 4 °C. The cell lysates in each well were then
separately centrifuged at 10,000 ⫻ g for 10 min at 4 °C to sediment the TX100-insoluble (pellet) cellular fraction, and the
TX100-insoluble fraction was resuspended in 100 l of 2%
SDS-urea sample buffer (2% (w/v) SDS, 8 M urea, 50 mM TrisHCl, 50 mM DTT, 0.1% (w/v) bromphenol blue, pH 6.8) for 15
min at 65 °C. The TX100-soluble proteins in the supernatant
solution were precipitated by the addition of TCA (final concentration of 10% (w/v)), washed three times with cold (4 °C)
acetone, air-dried, and dissolved by incubation for 15 min at
65 °C in 100 l of SDS-urea sample buffer. Equal volumes of the
protein-SDS-urea sample buffer solutions were resolved by
SDS-PAGE and transferred to PVDF membrane by Western
blotting. The relative levels of biotinylated AP substrate-containing fusions segregating into the TX100-soluble and -insoluble cellular fractions were estimated by probing the blots with
streptavidin conjugated to HRP as described under “Western
blotting and Quantification of Signals.” AP substrate-containing fusion protein levels and the biotin ligase-containing fusion
protein levels in each of the cellular fractions were estimated by
probing duplicate blots with antibodies directed against the
epitope tags, either FLAG, HA, or V5, that were engineered into
the fusions.
Fluorescent Labeling and Confocal Laser-scanning Microscopy—We utilized fluorescent labeling methods in conjunction
with confocal laser microscopy to visualize the subcellular distribution and localization of the D2R-AP3rd-loop substrate protein, the biotinylated D2R-AP3rd-loop substrate, and the co-expressed biotin ligase fusion that mediated the biotinylation.
The relative subcellular localization of the D2R-AP3rd-loop protein substrate and the subset of the D2R-AP3rd-loop protein that
was biotinylated was visualized in the same cells using doublelabeling techniques. The subcellular localization of the biotin
ligase fusion was visualized in a separate set of cells. HEK293T
cells were plated on BD BioCoat poly-D-lysine-coated 12-mm
diameter glass coverslips (BD Biosciences) in 24-well plates
(2 ⫻ 105 cells/well) and cultured using the biotin-depleted
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specific bands was subtracted to estimate the D2R-specific
signal.
Relative Biotinylation Efficacy (RBE) Derivations—RBE values were calculated by dividing the percentage of the biotinylated AP fusion that segregated into the TX100-insoluble portion by the percentage of the total parent AP substrate protein
that was found there. For example, the percentage of the total
biotinylated D2R-AP3rd-loop that segregated into the TX100insoluble fraction was ⬃8%, when biotinylation was mediated
by the plasma membrane-targeted biotin ligase NM-BL,
although the vast majority (⬃80%) of the parent D2R-AP3rd-loop
protein substrate is found in that fraction. Consequently, the
RBE for the biotinylation of TX100-insoluble D2R-AP3rd-loop
by NM-BL is 8/80, or 0.1, and suggests that biotinylation of
D2R-AP3rd-loop in the TX100-insoluble fraction occurred at
only 10% of the frequency of biotinylation of the TX100-soluble
D2R-AP3rd-loop molecules.
Statistical Analyses—Statistical analyses were performed
using Microsoft Excel or GraphPad Prism 4 software. The twosample t test for unequal variances with two-tailed p values was
utilized throughout for comparisons of independent mean values. For multiple comparisons, one way-analysis of variance
(ANOVA) was applied and, when applicable, followed by
Tukey’s post hoc analysis.

RESULTS
The Majority of Plasma Membrane-expressed D2Rs, but Not
MORs, Segregate into TX100-insoluble Fractions—Cells transiently expressing either D2R or MOR constructs were treated
so as to specifically biotinylate cell surface proteins and then
solubilized in a solution of 2% (v/v) TX100 at 4 °C, and the
relative levels of biotinylated cell surface receptor segregating
into the TX100-soluble and -insoluble cellular fractions were
isolated and estimated as described under “Materials and
Methods.” Greater than 70% of the plasma membrane-expressed wild-type or FLAG-tagged D2R, but less than 30% of
MOR, segregated into the TX100-insoluble fraction (Fig. 2,
A–D).
Dopamine Treatment Reduces the Levels of TX100-insoluble
D2R Expressed at the Plasma Membrane—Treatment of the
intact cells with dopamine (10 M for 30 min) decreased the
levels of TX100-insoluble plasma membrane-expressed D2R by
more than 50% (Fig. 2, E and F). In contrast, the dopaminemediated reduction in the levels of cell surface TX100-soluble
D2R, was less than 10% (Fig. 2, E and F) and significantly less
than the reduction observed for the TX100-insoluble form.
TX100-insoluble D2R-containing Fractions Do Not Correspond to Canonical Lipid Rafts—Next, we asked if the detergent-insoluble D2R-containing membrane fractions possessed
biochemical properties that have been attributed to canonical
lipid raft fractions. These biochemical features include 1) resistance to solubilization in cold non-ionic detergents, 2) lower
density compared with most other detergent-resistant cell
structures, and 3) disruption by cholesterol depletion (6).
HEK293T cell endogenously express flotillin, a conventional
marker for lipid raft-containing membrane fractions (27), and
we compared the densities of D2R and flotillin-containing
TX100-insoluble membrane fractions by layering these memJOURNAL OF BIOLOGICAL CHEMISTRY
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mouse monoclonal, the Alexa Fluor 594-conjugated goat antimouse secondary antibody, and the Alexa Fluor 488-conjugated streptavidin).
Western Blotting and Quantification of Protein Signals—Proteins resolved by SDS-PAGE were transferred to methanolwetted PVDF membranes by Western blotting using wet electrophoretic elution buffer (25 mM Tris base, 192 mM glycine,
10% (v/v) methanol, 0.1% (w/v) SDS, pH ⬃8.3). For antibodybased detection, the remaining protein binding sites on the blot
were then blocked by incubation with 10% (w/v) nonfat dry
milk reconstituted in PBS (1 h at 20 °C). Nonspecific protein
binding sites on blots probed with streptavidin for identification of biotinylated proteins were blocked instead by incubating
the blot with 3% (w/v) bovine serum albumin in PBS (1 h at
20 °C). V5 epitope-tagged proteins were detected by incubating
blots with an HRP-conjugated anti-V5 antibody (Invitrogen;
1:5000 in 10% nonfat milk in 1⫻ PBS). FLAG epitope-tagged
protein bands were detected using an HRP-conjugated mouse
monoclonal anti-FLAG M2 antibody (Sigma-Aldrich; 1:5000
dilution in 10% nonfat milk in 1⫻ PBS). HA epitope-tagged
D2R signal was detected with anti-HA.11 monoclonal antibody
(Covance; 1:1000 dilution in 10% nonfat milk in 1⫻ PBS). Biotinylated protein bands were detected using HRP-conjugated
streptavidin (Invitrogen; 1:5000 in PBS containing 3% (w/v)
BSA). Flotillin was detected with anti-flotillin 1 rabbit polyclonal antibody (Sigma-Aldrich; 1:1000 dilution in 10% nonfat
milk in 1⫻PBS). After incubation with the primary antibodies
or HRP-conjugated streptavidin, the blots were washed three
times (10 min each) in PBS containing 0.1% (v/v) Tween 20
(PBS-T). If the primary antibody was not directly conjugated to
HRP, the membrane was then incubated with appropriate
HRP-conjugated secondary antibodies (Jackson Immunoresearch) and washed four times in PBS-T. Chemiluminescent
signals catalyzed by the HRP enzyme were obtained using
Supersignal West Femto substrate (Pierce-Thermo Fisher Scientific) and detected using a Chemidoc XRS Molecular Imager
(Bio-Rad). Images were collected using exposure settings that
did not saturate any of the charge-coupled device camera pixels. The intensity of each band was quantified using ImageJ
image processing and analysis software (National Institutes of
Health, Bethesda, MD). In order to be able to directly compare
the signals from the TX100-soluble and -insoluble fractions of a
cell sample, the proteins from these fractions were loaded onto
the same polyacrylamide gel and transferred to a single blot.
The chemiluminescent signals from these fractions were then
developed on that blot so that ratio of protein signals from the
TX100-soluble and -insoluble fraction accurately represented
the ratio of the protein levels in these fractions. Signals from
serial dilutions of protein samples were evaluated to ensure that
all quantifications were performed in the linear range of the
signal protein function.
D2R was visualized as multiple bands on Western blots, and
all bands 50 kDa (the approximate molecular mass of the monomeric long form of human D2R) or higher were counted
together as the D2R signal from a particular cell sample. Signal
that was not specific to D2R expression was identified by examining appropriate control samples, and signal from these non-
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FIGURE 2. The majority of cell surface (plasma membrane-expressed)
D2R segregates into the TX100-insoluble cellular fraction, and dopamine treatment produces a loss of cell surface D2R from both TX100soluble and -insoluble fractions. A, representative image of a Western blot
of cell surface proteins isolated by surface biotinylation from TX100-soluble
(S) and TX100-insoluble fractions (I) from HEK293T cells expressing FLAGtagged D2R, probed with anti-FLAG antibody. The left two lanes are from
control cells transfected with empty vector. B, representative image of a
Western blot, specifically of cell surface proteins, from TX100-soluble (S) and
TX100-insoluble fractions (I) from HEK293T cells expressing wild-type (WT)
D2R, probed with an antibody targeted against a peptide sequence within
the D2R protein. The left two lanes are from control cells transfected with
empty vector. C, representative image of a Western blot, specifically of cell
surface proteins from TX100-soluble (S) and TX100-insoluble fractions (I) from
HEK293T cells expressing FLAG-tagged MORs, probed with anti-FLAG antibody. The left two lanes are from control cells transfected with empty vector.
D, quantification of levels of cell surface D2R and MOR constructs that segregate into TX100-soluble (white bars) and insoluble (black bars) cellular fractions, expressed as a percentage of the total cell surface signal for the respective receptor (mean ⫾ S.E. (error bars); n ⫽ 3– 4 separate experiments). E,
representative image of a Western blot depicting the loss of surface D2R that
segregates into TX100-soluble and -insoluble fractions (top left and right panels, respectively) after dopamine treatment (10 M, 30 min) of HEK293T cells.
The D2R signal was obtained by probing the blots with an antibody directed
against the D2R construct. Note that the D2R signals in the blot of TX100soluble protein (top left) cannot be directly compared with the D2R signal in
the blot of TX100-insoluble protein (top right) because the signal amplification is different across the two panels. Western blots, probed with streptavidin, of total biotinylated surface protein segregating into TX100-soluble and
-insoluble fractions from the respective cell samples, are depicted in the bottom panels and were used as loading controls. However, the effect of dopamine treatment on the levels of D2R segregating into either the TX100soluble or -insoluble fractions may be discerned. F, quantification of D2R
remaining in the TX100-soluble (Sol.; white bar) and insoluble (Ins.; black bar)
plasma membrane fractions after dopamine treatment, expressed as a percentage of surface D2R found in the TX100-soluble or -insoluble fractions,
respectively, from cells not treated with dopamine (mean ⫾ S.E.; n ⫽ 5 separate experiments). Although both TX100-soluble and -insoluble surface D2R
fractions were significantly decreased after dopamine treatment (#, p ⬍ 0.05),
the dopamine-mediated decrease in cell surface D2R was significantly
greater for the TX100-insoluble fraction (*, p ⬍ 0.01, t test).

branes onto solutions containing increasing concentrations of
sucrose. We measured the percentage of each of the proteins
that remained buoyant after centrifugation and found that, on
average, the D2R-containing TX100-insoluble membrane was
significantly denser than membrane containing the lipid raft
marker, flotillin (Fig. 3A).
Incubation of cells with cholesterol chelating agents, such as
M␤CD, results in increased detergent solubility of canonical
lipid raft proteins (6). As expected, the ratio of TX100-soluble
to insoluble flotillin was significantly increased in M␤CDtreated HEK293T cells (Fig. 3, B and D). However, M␤CD treatment did not increase the TX100 solubility of D2R (Fig. 3, B
and C).
In-cell Biotin Transfer Assay to Assess Cellular Interactions
between D2R and Plasma Membrane-targeted Proteins—The
biotinylation interaction assay utilized the E. coli biotin ligase,
BirA, that specifically biotinylates a unique AP sequence (20).
The substrate AP sequence was inserted into D2R, whereas
BirA was fused to other cellular proteins, and the D2R-AP substrate and a biotin ligase enzyme fusion were co-expressed in
HEK293T cells cultured in biotin-depleted medium. Biotinylation of the AP sequence following a brief treatment of the intact
living cells with biotin provides evidence for proximal contact
of the D2R-AP substrate and biotin ligase-containing fusion
(Fig. 4A).
Two D2R-AP fusion constructs were tested: D2R-AP3rd-loop,
in which the AP sequence was inserted into the third cytoplasmic loop of FLAG-tagged D2R, and D2R-APC-tail, where AP was
tethered to the D2R C-tail. We found that, as observed earlier
with the wild-type and FLAG-tagged D2R construct, the majority of the D2R-AP3rd-loop (81 ⫾ 2%) and D2R-APC-tail (72 ⫾ 2%;
mean ⫾ S.E., n ⫽ 6 – 8) protein segregated into the TX100insoluble cellular fraction.
In the first series of experiments, the biotin ligase was targeted to the plasma membrane by fusion with plasma membrane-targeting motifs from either LYN kinase (LYN-BL) (22),
KRAS (KRAS-BL) (28), neuromodulin/GAP-43 (NM-BL) (29),
or the kinase LCK (LCK-BL) (30).
We then examined the distribution of the D2R-AP substrate
that was specifically biotinylated by the above biotin ligase
fusions. In contrast to what was observed for the distribution of
the parent D2R-AP substrate, in each case, the majority (⬃86 –
90%) of the biotinylated D2R-AP was found in the TX100-soluble fraction. Biotinylated D2R-AP was barely detectable in the
TX100-insoluble fraction, although most of the D2R-AP substrate is found in this fraction. The results obtained with
LYN-BL and KRAS-BL are detailed in Fig. 4, B–D, and the inaccessibility of the TX100-insoluble form of D2R-AP to other
plasma membrane-targeted biotin ligase fusions is summarized
in Fig. 11.
It is important to note that streptavidin, which we used to
probe for biotinylated D2R-AP substrates in the Western blots,
binds nonspecifically to two bands from HEK293T cells that
appear between 50 and 75 kDa. The binding of streptavidin to
these bands is nonspecific because it occurs in samples derived
from biotin-starved cells and also in the absence of expression
of either a biotin ligase or the target AP-containing substrates
(see Fig. 4B). In addition, we found that the intensity of these
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FIGURE 3. The TX100-insoluble D2R-containing membrane does not correspond to canonically defined lipid raft fractions. A, quantification of the
buoyancy of TX100-insoluble D2R or flotillin-containing membrane fractions
from HEK293T cells layered onto solutions containing increasing concentrations of sucrose indicates that the D2R-containing TX100-insoluble membrane is on average denser than TX100-insoluble membrane containing flotillin. The graph represents the percentage of the total TX100-insoluble D2R
or endogenously expressed flotillin that remained floating at the surface of
the indicated sucrose solutions after centrifugation. The solid line with filled
triangles represents the percentage of floating D2R-containing TX100-insoluble membranes. The dashed line with filled black circles represents the percentage of floating flotillin-containing TX100-insoluble membrane (mean ⫾
S.E. (error bars); n ⫽ 4 separate experiments; *, p ⬍ 0.01, ANOVA shows significant difference in buoyancy between D2R and flotillin at 30 and 40% sucrose
concentrations). B, the TX100 solubility of D2R is unaffected by treatment
with the cholesterol chelating agent M␤CD. Representative image of a Western blot depicting the partitioning into TX100-soluble (S) and TX100-insoluble fractions (I) of transiently expressed cell surface D2R (top) or endogenously expressed flotillin (bottom) from HEK293T cells. Samples in lanes
marked with a plus sign were from cell cultures treated with M␤CD (10 mM, 1 h,
in serum-free medium), whereas samples in lanes marked with a minus sign
were from control cells not treated with M␤CD. Cell surface proteins were
specifically isolated via cell surface biotinylation. C, quantification of the partitioning of cell surface D2R into TX100-soluble (white bars) and TX100-insoluble fractions (black bars) after M␤CD treatment (⫹) expressed as a percentage of the total cell surface D2R in untreated cells (⫺) (mean ⫾ S.E.; n ⫽ 3
separate experiments). D, quantification of the partitioning of cell surface
flotillin into TX100-soluble (white bars) and TX100-insoluble fractions (black
bars) after M␤CD treatment (⫹) expressed as a percentage of the total cell
surface flotillin in untreated cells (⫺) (mean ⫾ S.E.; n ⫽ 3 separate experiments; *, p ⬍ 0.05, significant difference compared with no M␤CD treatment,
t test).

FIGURE 4. TX100-insoluble D2R-AP fusion substrates exhibit restricted
accessibility to multiple plasma membrane-targeted biotin ligases.
A, schematic representation of in-cell biotin transfer assay. Proximal interaction of the D2R-AP fusion substrate and BL enzyme-containing constructs
allows for the specific attachment of biotin (B) to the unique AP sequence.
Biotin transfer cannot occur if the biotin ligase enzyme and the AP substrate
are unable to interact. B, HEK293T cells transiently co-expressing the D2RAP3rd-loop construct and either LYN-BL or KRAS-BL were cultured in biotindepleted medium. The intact cultured cells were then treated with 10 M
biotin for 5 min before solubilization in TX100 solution. The panel depicts a
representative image of a Western blot of TX100-soluble (S) and TX100-insoluble fractions (I) derived from the above cell preparations. The blot was
probed with HRP-conjugated streptavidin to assess the level of biotinylated
D2R-AP3rd-loop that segregated into either the TX100-soluble or TX100-insoluble
biochemical fractions. The panels labeled LYN-BL and KRAS-BL depict signal from
cells transiently co-expressing D2R-AP3rd-loop and the LYN-BL or KRAS-BL construct, respectively. The panel labeled ctrl1 (control 1) depicts signal from cells that
transiently expressed only D2R-AP3rd-loop and were not transfected with cDNA for
the biotin ligase fusions. The panel labeled ctrl2 (control 2) depicts signals from
cells that transiently expressed only the NM-BL fusion and were not transfected
with cDNA for any AP-containing fusion. The panel labeled ctrl3 (control 3) depicts
signal from cells transiently co-expressing D2R-AP3rd-loop and NM-BL and were
not treated with biotin. It is important to note that streptavidin binds nonspecifically to bands that appear between 50 and 75 kDa. The binding of streptavidin to
these bands is nonspecific because it occurs in samples derived from biotinstarved cells (ctrl3) and in the absence of expression of either biotin ligases
(ctrl1) or target substrates (ctrl2). C, quantification of levels of biotinylated D2RAP3rd-loop segregated into TX100-soluble (white bars) and TX100-insoluble (black
bars) cellular fractions expressed as a percentage of the total biotinylated D2RAP3rd-loop signal (mean ⫾ S.E. (error bars); n ⫽ 3– 4 separate experiments). D, the
experiments described in B and C were repeated with the D2R-APC-tail fusion
construct and either LYN-BL or KRAS-BL, respectively, and the graph represents a
quantification of the levels of biotinylated D2R-APC-tail that subsequently segregated into TX100-soluble (white bars) and TX100-insoluble (black bars) cellular
fractions expressed as a percentage of the total cellular biotinylated D2R-APC-tail
signal (mean ⫾ S.E.; n ⫽ 3 separate experiments; ANOVA shows no significant
differences in the biotinylation of the TX100-insoluble D2R-AP substrates by the
different membrane-targeted ligase constructs, p ⫽ 0.75).
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FIGURE 5. Subcellular localization of LYN-BL, KRAS-BL, D2R-AP3rd-loop,
and D2R-AP3rd-loop that was biotinylated by either LYN-BL or KRAS-BL.
Biotin-depleted HEK293T cells, transiently expressing the indicated protein
constructs, were treated with 10 M biotin for 5 min before staining with the
fluorescent dye-conjugated probes. A, representative image of the distribution of LYN-BL (left) and KRAS-BL (right) in cells transiently co-expressing D2RAP3rd-loop. B, left, representative image of the distribution of the D2R-AP3rd-loop
protein in cells transiently co-expressing LYN-BL. Center, representative
image of the distribution of LYN-BL-mediated biotinylation of D2R-AP3rd-loop
visualized by staining with streptavidin conjugated to an Alexa Fluor 488 dye.
Right, image formed by merging images from the left and center panels. Scale
bar, 20 m. C, left, representative image of the distribution of the D2RAP3rd-loop protein in HEK293T cells transiently co-expressing KRAS-BL. Center,
representative image of the distribution of KRAS-BL-mediated biotinylation
of D2R-AP3rd-loop visualized by staining with streptavidin. Right, image formed
by merging images from the left and center panels.

proteins to detergent-insoluble membrane fractions that
have been canonically defined as lipid raft fractions (22, 29).
When expressed transiently in HEK293T cells, ⬃28% of the
NM-AP fusion construct segregated into the TX100-insoluble fraction (Fig. 6A).
Biotinylation in intact HEK293T cells of the NM-AP substrate transiently co-expressed with either LYN-BL or
KRAS-BL was allowed to occur as described above for the
D2R-AP fusions. After the cells were solubilized in cold TX100
solution, we found that the fraction of biotinylated NM-AP that
segregated into the TX100-insoluble fraction was comparable
and not significantly different from the proportion of the parent
NM-AP protein that segregated into that fraction (Fig. 6, A and
B). In other words, the segregation of biotinylated NM-AP into
the TX100-soluble and -insoluble fractions paralleled the segregation of the parent NM-AP protein (Fig. 6, A and B). These
results stand in stark contrast to that observed with D2R-AP
substrates, where ⬎70% of the parent D2R-AP protein segregates into the TX100-insoluble fraction, but ⬍20% of the biotinylated substrate segregates there. Thus, the inaccessibility to
cellular biotinylation exhibited by the TX100-insoluble pool of
D2R-AP molecules did not extend to the TX100-insoluble pool
of another plasma membrane-targeted AP substrate-containing construct.
VOLUME 288 • NUMBER 18 • MAY 3, 2013
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nonspecific bands relative to the signal from specific biotinylated D2R-AP-containing substrate varies from experiment to
experiment (compare Figs. 4B and 7A). Therefore, in each
experiment, control samples from either biotin-starved cells or
cells not expressing the biotin ligase or the complementary
D2R-AP substrate were used to identify the signal that was specific to biotinylated D2R-AP.
The relative inability of the membrane-targeted biotin ligase
enzyme fusion proteins to access and biotinylate D2R-AP substrate that segregated into the TX100-insoluble fraction
prompted us to evaluate the TX100 solubility/insolubility of
these biotin ligase fusions. The percentage of the plasma membrane-targeted biotin ligase fusions that remained insoluble
after treatment with cold TX100 was 83 ⫾ 5% for LYN-BL, 18 ⫾
6% for KRAS-BL, 50 ⫾ 1% for NM-BL, and 82 ⫾ 3% for LCK-BL
(mean ⫾ S.E., n ⫽ 3–5).
Thus, we have tested the accessibility, in intact cells, of two
AP substrate-containing D2R constructs to four different
membrane-targeted biotin ligase enzyme constructs that varied
widely in their TX100 solubility. In all cases, the D2R-AP substrate molecules that segregated into the TX100-insoluble fraction appeared similarly inaccessible for biotinylation.
Plasma Membrane Localization of Membrane-targeted Biotin Ligase Fusions, LYN-BL and KRAS-BL, and Biotinylated
D2R-AP Substrate—To evaluate whether the above biotin
ligase enzyme fusion proteins were successfully targeted to
the plasma membrane, we utilized confocal laser-scanning
light microscopy. The left and right panels, respectively, in
Fig. 5A depict the subcellular localization of LYN-BL, a biotin ligase fusion that is predominantly TX100-insoluble,
and KRAS-BL, the fusion that segregates predominantly into
the TX100-soluble cellular fraction. Both LYN-BL and
KRAS-BL were found concentrated at the cell boundaries
(Fig. 5A), suggesting that these constructs were targeted to
the plasma membrane.
Previous studies examining the subcellular localization of
D2R in HEK293T, CHO, COS-7, HeLa, NG108-15, and striatal
neurons have showed that, although D2R is observed at the
plasma membrane, a significant fraction of D2R is retained
within intracellular compartments (31–33). We found that the
cellular distribution of the D2R-AP3rd-loop protein was consistent with these previous observations (Fig. 5, B and C, left panels). In contrast, streptavidin staining showed that biotinylation
of D2R-AP3rd-loop, which was mediated by LYN-BL or KRASBL, occurred predominantly at the cell boundaries and
appeared to reflect the plasma membrane targeting of LYN-BL
or KRAS-BL (Fig. 5, B and C, center panels).
The Cellular Inaccessibility for Biotinylation Demonstrated
by the TX100-insoluble D2R-AP Substrates Does Not Extend to
the TX100-insoluble Forms of other AP Substrate-containing
Fusion Constructs—We asked if the cellular inaccessibility for
biotinylation exhibited by the TX100-insoluble D2R-AP
substrates was a common property of all detergent-insoluble
membrane-targeted protein molecules. To answer that
question, the AP substrate was fused to the plasma membrane-anchoring motif from neuromodulin (NM-AP). The
NM-derived plasma membrane-targeting motif has been
previously utilized by other investigators to target fusion
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Cellular Accessibility for Biotinylation of TX100-soluble and
-insoluble D2R-AP3rd-loop and D2R-APC-tail Substrates Mediated by 1) V5 Epitope-tagged BL, 2) G␣i-BL, 3) Arr-BL, and 4)
D2R-BL—The E. coli biotin ligase, BirA, is a soluble cytoplasmic protein, and hence the BL construct was utilized to test the
relative accessibility of the D2R-AP3rd-loop inserted into the
TX100-soluble and -insoluble membrane to freely diffusing
cytoplasmic molecules.
It is thought that D2R primarily produces cellular responses
via the activation of members of the pertussis toxin-sensitive
Gi/Go family of heterotrimeric G proteins (16, 17). Thus, the
G␣i-BL construct was utilized to evaluate how the two D2R
populations interacted with these physiologically important
transducers for D2R.
The Arr-BL fusion was constructed to evaluate the relative
ability of the D2R populations to interact with arrestins, proteins that serve both as important regulators and mediators of
G protein-coupled receptor signals (34). For example, arrestins
have been previously shown to interact with D2R to regulate
D2R trafficking in an agonist-dependent manner and also serve
as mediators of D2R signals (35–37).
MAY 3, 2013 • VOLUME 288 • NUMBER 18

Finally, the D2R-BL fusion was constructed to evaluate the
accessibility that D2R molecules segregating into the TX100soluble and -insoluble fractions have for each other.
The biotinylation of the D2R-AP3rd-loop substrate was initiated in intact HEK293T cells, and the percentage of biotinylated D2R-AP3rd-loop substrate that subsequently segregated
into TX100-soluble and -insoluble cellular fractions is shown in
Fig. 7, A and B. The control panel (ctrl) in Fig. 7A allows for the
identification of bands that were not specific to biotinylated
D2R-AP substrate.
Confocal Microscopy Examination of the Cellular Localization of BL, Arr-BL, and G␣i-BL and the Biotinylated D2RAP3rd-loop Construct after Coexpression of the Complementary
Fusion Proteins—Although BL and Arr-YFP were largely
excluded from the nucleus, they were otherwise smoothly and
uniformly distributed through the cytoplasm (Fig. 8A, left and
center panel, respectively) and their expression pattern was
unaffected by the co-expression of D2R constructs.
Previously, we had reported that D2R co-expression alters
the subcellular distribution of G␣i1 in HEK293T cells (19). In
the absence of D2R, the expression of the G␣i1 is spread out
uniformly through the cytoplasm, and upon D2R co-expression, it moves toward the cell boundaries (19). In accordance
with these observations, when co-expressed with D2RAP3rd-loop, the expression of G␣i-BL construct was enriched at
the cell boundaries (Fig. 8A, right).
The localization of the D2R-AP substrate that was biotinylated specifically by co-expressed BL, Arr-BL, or G␣i-BL was
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FIGURE 6. Segregation of the biotinylated NM-AP fusion protein into
TX100-soluble and -insoluble cellular fractions after cellular biotinylation mediated by plasma membrane-targeted biotin ligase constructs.
HEK293T cells transiently co-expressing the indicated protein constructs
were cultured in biotin-depleted medium. The intact cultured cells were then
treated with 10 M biotin for 5 min before solubilization in TX100 solution. A,
quantification of the relative levels of NM-AP protein expressed as a percentage of total NM-AP protein signal (mean ⫾ S.E. (error bars); n ⫽ 4 separate
experiments). Inset, representative image of a Western blot of cells expressing
NM-AP and probed with an antibody directed against the NM-AP construct to
assess the segregation of the NM-AP protein into these fractions. B, quantification of levels biotinylated NM-AP expressed as a percentage of total biotinylated NM-AP (mean ⫾ S.E.; n ⫽ 3 separate experiments). Inset, representative images of Western blots of biotinylated NM-AP substrate by plasma
membrane-targeted biotin ligase as indicated. ANOVA indicated no significant differences between the percentage of biotinylated NM-AP substrate
recovered in the TX100-insoluble fraction when biotinylation was mediated
by the biotin ligases and no significant differences between from the percentage of NM-AP protein and biotinylated NM-AP segregating into the TX100soluble and insoluble fractions, p ⫽ 0.71.

FIGURE 7. Segregation of biotinylated D2R-AP3rd-loop fusion constructs
into TX100-soluble and -insoluble fractions after cellular biotinylation
mediated by various BL fusion constructs. HEK293T cells transiently co-expressing the indicated protein constructs were cultured in biotin-depleted
medium. The intact cultured cells were then treated with 10 M biotin for 5
min before solubilization in TX100 solution. A, representative images of Western blots of biotinylated D2R-AP3rd-loop after cellular biotinylation mediated
by BL, Arr-BL, G␣i-BL, or D2R-BL. The leftmost panel (ctrl) depicts a Western
blot of membranes from biotin-depleted cells that co-expressed D2R-AP and
Arr-BL but were not treated with biotin and allows for distinguishing between
the nonspecific signal and the specific signal from the biotinylated D2R-AP
substrate. B, quantification of levels of biotinylated D2R-AP3rd-loop expressed
as a percentage of total biotinylated D2R-AP3rd-loop (mean ⫾ S.E., n ⫽ 3– 4
separate experiments; ANOVA indicated no significant differences in the percentage of insoluble D2R-AP3rd-loop biotinylation by BL, Arr-BL, G␣i-BL, or
D2R-BL, p ⫽ 0.128).
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visualized by staining with streptavidin. The relative subcellular
localization of D2R-AP3rd-loop protein and the subset of the
biotinylated D2R-AP3rd-loop molecules is illustrated in Fig. 8,
B–D, respectively. When biotinylation was catalyzed by either
BL or Arr-BL, the distribution of biotinylated D2R-AP largely
coincided with that of D2R-AP, which was distributed, as illustrated earlier, in an irregular manner throughout the cytoplasm
and at the cell boundaries (Fig. 8, B and C, respectively). When
biotinylation was mediated by G␣i-BL, the biotinylated D2RAP3rd-loop was found most concentrated at the cell boundaries
(Fig. 8D). Thus, it may be concluded from the imaging experiments that biotinylation of the D2R-AP substrate occurred in
the subcellular regions in which both the D2R-AP and the biotin ligase enzyme fusion were co-expressed (Figs. 5 and 8).
D2R Co-expression Blocks the M␤CD-mediated Enhancement of the TX100 Solubility of G␣i1—G protein G␣ subunits
associate with cell membranes via post-translational lipid modifications (38). In addition, it has been shown that a proportion
of the cellular G␣i G protein segregates into detergent-resistant
buoyant biochemical fractions that are enriched in cholesterol
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and sphingolipids (39, 40). We asked if D2R co-expression
could alter the “lipid raft properties” of G␣i subunits, prompted
by our previous observation of D2R-mediated relocalization of
G␣i to the plasma membrane.
In accordance with these lipid raft properties, we found that
the majority of the G␣i1 subunit segregated into the TX100insoluble fraction and that, in the absence of D2R co-expression, treatment with the cholesterol chelating agent, M␤CD (10
mM, 1 h at 37 °C), significantly increased the TX100 solubility of
the G␣i1 (Fig. 9). Co-expression of D2R significantly decreased
the TX100 solubility of G␣i1 and prevented the increase in
TX100 solubility of G␣i1 produced after M␤CD treatment
(Fig. 9).
Effect of Dopamine Treatment on the Biotinylation of the
D2R-AP Substrates—We also examined the effect of dopamine
treatment on the biotinylation of both D2R-AP fusion substrates. Cells co-expressing the D2R-AP substrate and a biotin
ligase fusion were treated with 10 M dopamine for 30 min. We
examined biotinylation catalyzed by BL, Arr-BL Galphai-BL,
and D2R-BL and the plasma membrane-targeted biotin ligase
fusions described earlier. A significant dopamine-mediated
enhancement of the biotinylation of the D2R-AP substrates was
only observed with Arr-BL (Fig. 10).
To visualize the dopamine enhancement of specific biotinylation of the DR-AP substrate, it is important to distinguish
between bands produced by nonspecific streptavidin binding
and the specific signal produced as a result of biotinylation of
the D2R-AP substrate (Fig. 10A, compare top left and right
panels).
RBE of TX100-insoluble versus TX100-soluble AP-containing
Substrates—To more accurately quantify the relative efficacy at
which detergent-insoluble versus soluble forms of an AP subVOLUME 288 • NUMBER 18 • MAY 3, 2013
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FIGURE 8. Cellular distribution of BL, Arr-YFP, and G␣i-BL and of D2RAP3rd-loop biotinylation mediated by either BL, Arr-YFP, or G␣i-BL.
HEK293T cells transiently expressing the indicated protein constructs were
cultured in biotin-depleted medium were treated with 10 M biotin for 5 min
before staining with the fluorescent dye-conjugated probes. A, representative image of the distribution of BL (left), Arr-YFP (center), and G␣i-BL (right) in
cells transiently co-expressing D2R-AP3rd-loop. Scale bar, 20 m. B, left, representative image of the distribution of the D2R-AP3rd-loop protein expressed in
cells transiently co-expressing BL. Center, representative image of the distribution of D2R-AP3rd-loop biotinylation mediated by the BL construct and visualized by staining with streptavidin conjugated to the green Alexa Fluor 488
dye. Right, image formed by merging images from left and center panels. C,
visualization of the biotinylation of D2R-AP3rd-loop as described in B, where the
biotinylation was mediated by Arr-BL instead of BL. D, visualization of the
biotinylation of the D2R-AP3rd-loop fusion as described in B, where the biotinylation was mediated by G␣i-BL instead of BL.

FIGURE 9. D2R-AP3rd-loop co-expression abolishes the enhancement of
the TX100 solubility of G␣i-BL produced after M␤CD treatment. A, representative image of a Western blot of the distribution of transiently expressed
G␣i-BL in TX100-soluble and -insoluble cellular. Samples in the four right lanes
originated from HEK293T cells transiently co-expressing the D2R-AP3rd-loop
construct. Lanes labeled with a plus sign were from to cell samples treated
with M␤CD (10 mM, 1 h, in serum-free medium). B, quantification of levels of
G␣i-BL signal expressed as a percentage of total G␣i-BL (mean ⫾ S.E. (error
bars); n ⫽ 3 separate experiments). ANOVA indicated significant differences
in the percentage of G␣i-BL distribution within the different treatment
groups, p ⬍ 0.0001. Tukey’s post hoc test analysis indicated a significant
effect of M␤CD treatment on the percentage of G␣i-BL recovered in the insoluble fraction when G␣i-BL was expressed alone, p ⬍ 0.001, but not when
G␣i-BL was expressed with D2R-AP3rd-loop.

Plasma Membrane Compartmentalization of D2 Dopamine Receptors

strate-containing molecule is biotinylated, it is necessary to
account for the unequal segregation of the parent AP substrate
into these fractions. To normalize for the unequal distribution
of the AP substrates into the TX100-insoluble versus the soluble fraction, we divided the percentage of the biotinylated AP
fusion, which segregated into the TX100-insoluble portion, by
the percentage of the total parent AP substrate protein that was
found there. The resulting fraction was termed RBE, which is
the efficacy at which the TX100-insoluble AP substrate is biotinylated with respect to the TX100-soluble form. An RBE of less
than 1 indicates that a smaller proportion of the AP substrate
that segregated into the TX100-insoluble fraction was biotinylated when compared with the TX100-soluble fraction. In other
words, AP molecules segregating into the TX100-insoluble
fraction were biotinylated at a lower frequency than TX100soluble molecules and were therefore less accessible for biotinylation. RBE values close to 1 suggest that TX100-insoluble
and -soluble molecules are being biotinylated at approximately
equal frequencies and were similarly accessible. The RBEs for
different pairs of AP substrates and biotin ligase-containing
fusion constructs are summarized in the graph depicted in Fig.
11.

DISCUSSION
Several important conclusions may be drawn from an examination of the derived RBE values depicted in Fig. 11.
The Cellular Accessibility, along the Plane of the Plasma
Membrane, of the Detergent-resistant Form of D2R Is Severely
Limited Relative to the Detergent-soluble Form—RBEs obtained
with the D2R-AP substrates and the membrane-targeted biotin
ligase fusions, NM-BL, LYN-BL, LCK-BL, and KRAS-BL, were
less than 0.2 (Fig. 11), indicating that the biotinylation of the
MAY 3, 2013 • VOLUME 288 • NUMBER 18

FIGURE 11. Comparison of the relative biotinylation efficacy of the
TX100-insoluble D2R-AP and NM-AP biotinylation substrates obtained
with different BirA biotin ligase-containing fusion constructs. The graph
depicts the RBE values (percentage of biotinylated AP substrate segregating
into TX100-insoluble fraction/percentage of total AP substrate segregating
into the TX100-insoluble fraction) for the biotinylation of the D2R-AP (black
bars) and NM-AP (hatched bars) substrates mediated by the different biotin
ligase-containing fusion constructs (mean ⫾ S.E. (error bars); n ⫽ 3– 4 separate experiments). ANOVA indicated significant differences between RBEs for
the different biotin ligase constructs at D2R-AP3rd-loop and at D2R-APC-tail, p ⬍
0.0001. Tukey’s post hoc analysis indicated no significant differences
between RBEs obtained with the different plasma membrane-targeted
ligases at either D2R-AP3rd-loop or D2R-APC-tail. Tukey’s post hoc analysis also
indicated no significant differences between RBEs obtained with BL, Arr-BL,
G␣i-BL, or D2R-BL at either D2R-AP3rd-loop or D2R-APC-tail. However, RBEs
obtained with plasma membrane-targeted biotin ligases at D2R-AP3rd-loop or
D2R-APC-tail were significantly less than RBEs obtained with BL, Arr-BL, G␣i-BL,
or D2R-BL, p ⬍ 0.05. Finally, RBEs obtained with NM-AP and the different
plasma membrane-targeted biotin ligases were not significantly different
from each other. All RBEs obtained with D2R-AP3rd-loop and at D2R-APC-tail
with the exception of the D2R-APC-tail and the Arr-BL pair were significantly
different from 1 (based on 95% confidence intervals). RBEs obtained with
NM-AP and the different plasma membrane-targeted biotin ligases were not
significantly different from 1 (based on 95% confidence intervals).

TX100-insoluble D2R-AP substrate molecules by the plasma
membrane-targeted biotin ligases occurred at less than 20% of
the frequency of the TX100-soluble D2R-AP molecules. Thus,
the most plausible explanation is that D2R-AP molecules that
segregate into the TX100-insoluble fraction originate from a
plasma-membrane structure that exists within living cells to
restrict their accessibility to other plasma membrane-associated proteins (i.e. they are compartmentalized).
An alternative explanation that could be invoked for the relative inaccessibility of the detergent-insoluble D2R-AP substrates for cellular biotinylation is as follows. D2R adopts two
different conformations in living cells: a conformation that is
resistant to solubilization and another more detergent-soluble
form. By coincidence, the AP substrate was inserted into a
region in D2R that is buried in the detergent-insoluble conforJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 10. Dopamine-mediated enhancement of D2R-AP3rd-loop biotinylation mediated by Arr-BL. HEK293T cells transiently co-expressing the D2RAP3rd-loop and Arr-BL were cultured in biotin-depleted medium. The intact
cultured cells were then treated with 10 M biotin for 5 min before solubilization in TX100 solution. A, top, representative image of a Western blot
probed with streptavidin to assess the levels of biotinylated D2R-AP3rd-loop
segregating into TX100-soluble (S) and TX100-insoluble (I) fractions from
HEK293T cells after cellular biotinylation mediated by Arr-BL. Lanes labeled
with a plus sign were from cells treated with dopamine (10 M, 30 min). The
top left panel (ctrl) depicts a Western blot of membranes from biotin-depleted
cells that co-expressed D2R-AP and Arr-BL but were not treated with biotin
and allows for distinguishing between the nonspecific signal and the specific
signal from the biotinylated D2R-AP substrate. Bottom, the levels of D2RAP3rd-loop protein in the different cell fractions were assessed by probing the
Western blot with an anti-FLAG tag antibody targeted against the D2RAP3rd-loop construct and served as the loading control. B, quantification of the
levels of biotinylated D2R-AP3rd-loop in TX100-soluble and -insoluble cell fractions after treatment of cells with dopamine expressed as a percentage of the
biotinylated D2R-AP3rd-loop signal from the corresponding cellular fraction
(TX100-soluble or -insoluble, respectively) from cells not treated with dopamine (mean ⫾ S.E. (error bars); n ⫽ 3 separate experiments; *, p ⬍ 0.05, t test).
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rotate freely to allow the biotin ligase enzyme to better interact
with the AP substrate.
Enhanced Accessibility of Cytoplasmic Molecules for Microcompartmentalized D2R—One explanation for the comparatively enhanced RBE exhibited by the soluble biotin ligase constructs, BL and Arr-BL, which can access D2R-AP substrates
from the cytoplasm, compared with the plasma membranetargeted biotin ligase fusions (Fig. 11), is that the compartmentalized detergent-resistant D2R is more accessible from the
cytoplasm than from the plane of the membrane.
The In-cell Biotin Transfer Assay with D2R Provides Unambiguous Evidence for the Existence of Plasma Membrane Microcompartments in Living Cells—Alternative explanations from
those listed above may be provided for the differing RBEs
obtained with the D2R-AP substrates and some of the biotin
ligase fusions. However, it is important to note that, with the
exception of the D2R-APC-tail-Arr-BL pair, all of the RBEs
obtained for the D2R-AP fusions were significantly less than 1
(Fig. 11). The latter observation unequivocally indicates that
the cellular accessibility of the detergent-insoluble D2R is
restricted when compared with the detergent-soluble D2R.
Because the biotinylation reaction was catalyzed in intact living
cells, before the cells were lysed in detergent, it may be concluded that the detergent-resistant D2R molecules are compartmentalized in intact living cells.
Furthermore, the use of the in-cell biotin transfer assay as a
valid measure of the relative ability of D2R to interact with
other cellular proteins is substantiated by results obtained with
Arr-BL. Arrestins are recruited to agonist-bound G proteincoupled receptors, including D2R (35–37), and dopamine
treatment significantly enhanced the Arr-BL-mediated biotinylation of both the detergent-soluble and -insoluble forms of
D2R-AP fusions. In fact, significant dopamine-mediated
enhancement of the biotinylation of the D2R-AP fusions only
occurred with Arr-BL (Fig. 10) and not with any of the other
BirA biotin ligase-containing fusions.
Both the Detergent-soluble and Microcompartmentalized
D2R Forms Respond to Dopamine in Intact Cells and Hence Are
Functional—The results with Arr-BL showing dopamine-mediated enhancement of biotinylation of both the detergent-soluble and the compartmentalized detergent-insoluble forms of
D2R (Fig. 10) indicate that they represent functional assemblies
of the receptor. Furthermore, dopamine treatment results in
loss of both detergent-soluble and insoluble forms of D2R from
the cell surface (Fig. 2, E and F). Interestingly, the loss of detergent-insoluble D2R from the cell surface produced by dopamine treatment was significantly greater than that of the
detergent-soluble D2R (Fig. 2, E and F), confirming that the
detergent-soluble and -insoluble D2R populations have either
intrinsically different biochemistries or originate from distinct
biochemical environments in the plasma membrane.
Plasma Membrane Compartmentalization May Be Invoked
to Explain Paradoxical Signaling Observations Previously
Reported with D2R—Cho et al. (36) reported that a D2R-elicited cellular response, thought to be mediated via the second
messenger, cAMP, was not desensitized after 40 min of dopamine pretreatment, although such pretreatment caused more
than 40% of the receptor to be internalized. It is expected that a
VOLUME 288 • NUMBER 18 • MAY 3, 2013

Downloaded from http://www.jbc.org/ at Univ of Rhode Island Library on January 24, 2019

mation but lies exposed at the surface in the detergent-soluble
conformation.
However, the explanation suggested above is unlikely because
we tested two different D2R-AP fusions, D2R-AP3rd-loop and
D2R-APC-tail, with AP insertions at two very dissimilar sites in
the D2R molecule. We found that that the TX100-insoluble
cellular fractions of both D2R-AP fusions were similarly inaccessible for biotinylation. In fact, in the D2R-APC-tail construct,
the AP tag was tethered to the end of the D2R C-tail using a long
(106-amino acid) flexible linker so as to extend the AP tag away
from D2R and allow the AP tag to freely interact with neighboring molecules.
The Detergent-insoluble D2R-containing Microcompartments Probably Contain G␣i Subunits and Multiple D2R
Molecules—It is interesting to note that the RBE values
obtained with D2R-AP and G␣i-BL or D2R-BL fusions were
significantly higher than those obtained with D2R-AP and the
plasma membrane-targeted biotin ligase fusions (Fig 11). The
relatively enhanced accessibility exhibited by G␣i-BL for
the detergent-insoluble fraction of D2R-AP may be explained if
G␣i subunits, as transducers of D2R signals (16, 17), are present
together with D2R in the detergent-insoluble microcompartments. One would expect that the frequency of interactions
between molecules located within the detergent-resistant D2R
compartment is likely to be higher than the frequency of interactions between the compartmentalized D2R and molecules
such as LYN-BL that are excluded from the compartment. Further support for such a scenario is provided by the observation
that the detergent solubility of G␣i is not enhanced by treatment with the cholesterol chelating agent, M␤CD, after D2R
co-expression (Fig. 9) (i.e. after D2R co-expression, the G␣i subunits acquire biochemical properties of the detergent-resistant
D2R). The relatively enhanced RBE values obtained with the
D2R-AP and D2R-BL (Fig. 11) constructs could be similarly
explained if the detergent-insoluble microcompartment structure contained multiple D2R molecules.
The above scenario, with D2R and G␣i subunits residing
together in the detergent-insoluble D2R microcompartments,
raises another question. Why was the RBE obtained with
G␣i-BL and the detergent insoluble D2R-AP less than 1 (Fig.
11)? In other words, why did the G␣i-BL-mediated cellular
biotinylation of D2R-AP occur at a lower frequency inside the
microcompartment than outside, although it would be reasonable to expect that the D2R-AP substrate molecules and G␣i-BL
enzyme molecules are more closely juxtaposed when they are
confined together within microcompartments? This question
may be answered if it is postulated that the D2R microcompartment has the properties of a rigid lattice or scaffold within
which components, such as the D2R and G protein transducers,
are embedded. The lattice could facilitate physiological interactions between the embedded components by orienting the
embedded components to contact each other at the physiologically relevant surfaces. Such a rigid lattice could, however,
hinder non-physiological interactions occurring between the
biotin ligase enzyme and AP substrate inserted artificially into
the G␣i subunits and D2R, respectively. The TX100-soluble
D2R-AP, may originate however, from a more fluid portion of
the plasma membrane, where both D2R-AP and G␣i-BL fusions
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FIGURE 12. Schematic depicting the two different pools of plasma membrane D2Rs. D2R is present as expressed in the plasma membrane in either a
detergent-resistant (region of the plasma membrane shaded in black) or
detergent-soluble form. The detergent-resistant form is functional and
responds to dopamine but is inaccessible to interacting nonspecifically with
other plasma membrane proteins and hence is compartmentalized. However, D2R interaction proteins, such as arrestins and G protein G␣i subunits,
are able to access the compartmentalized receptor. The detergent-soluble
form of D2R originates from a more fluid region of the plasma membrane,
allowing the receptor to more readily interact with other plasma membrane
proteins.
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loss of surface receptor should produce a shift in the dose-response curve to the right, but such a shift was paradoxically not
detected. To explain this anomalous result, we hypothesize that
the compartmentalized D2R, which we have shown is substantially internalized after dopamine treatment (Fig. 2, E and F),
does not contribute significantly to modulating the cAMP-mediated signal. Instead, the D2R-elicited cellular signal was mediated through the non-compartmentalized D2R, which we show
in this report is minimally internalized (Fig. 2, E and F).
The Detergent-resistant Pool of the Biotinylation Substrate,
NM-AP, Which Is Thought to Be Targeted to Hypothetical Lipid
Rafts, Does Not Appear to Be Compartmentalized in Living
Cells—An important feature of the graph depicted in Fig. 11 is
the very different RBEs obtained with D2R-AP and the plasma
membrane-targeted NM-AP biotinylation substrates. The
RBEs obtained with the NM-AP substrate were not significantly different from 1 (Fig. 11), suggesting that there was no
difference between the cellular accessibility of TX100-soluble
and -insoluble NM-AP molecules.
The biochemical properties of the plasma membrane-targeting peptide motifs derived from NM, the kinase LCK, and LYN
kinase, such as their relatively low detergent solubility, and
canonical assumptions about lipid rafts have led to suggestions
that they are targeted to lipid raft compartments. Furthermore,
these peptide motifs have been used extensively to target other
proteins, such as GFP, to these hypothetical structures (22, 29,
30) Similarly, the biochemical properties of the plasma membrane targeting motif from KRAS, such as the relatively high
detergent solubility, have been invoked to suggest that it targets
to the more fluid detergent-soluble non-raft regions of the
plasma membrane (28). However, the RBE values obtained with
the NM-AP substrate and NM-BL, LYN-BL, LCK-BL, and
KRAS-BL (Fig. 12) were similar and, as stated above, not significantly different from 1. Thus, it may be concluded that 1) the
accessibility of the detergent-insoluble form of NM-AP
(thought to originate from lipid rafts) to NM-BL, LYN-BL, and
LCK-BL (also thought to be predominantly targeted to lipid
rafts) is not different from the cellular accessibility to KRAS-BL
(which is predicted to be excluded from lipid rafts according to
conventional theory); 2) the cellular accessibility of the detergent-soluble form of NM-AP (which is expected to be excluded

from lipid rafts according to the lipid raft theory) to NM-BL,
LYN-BL, and LCK-BL (lipid raft-targeted) was not different
from the accessibility to KRAS-BL (lipid raft excluded); and 3)
the accessibility of TX00-insoluble NM-AP (thought to originate from lipid rafts) to all of the above biotin ligase fusions
(both raft-targeted and -excluded) was not different from the
accessibility of TX100-soluble NM-AP (raft-excluded) to the
same set of biotin ligase fusions. In summary, we found that
the detergent solubility of NM-AP could not be correlated with
compartmentalization of this construct in the plasma membrane, and our application of the in-cell biotin transfer assay
was unable to detect any indication of compartmentalization of
the presumed lipid raft-targeting peptides in living cells.
The deletion of peptide motifs, like those derived from NM,
LYN kinase, and LCK, which are thought to target proteins to
lipid rafts, can disrupt the cellular function of the resulting proteins (10). These observations have been cited to argue for the
existence of lipid raft compartments in living cells. However,
deletion of a protein motif that alters the detergent solubility of
the remaining fragment probably produces global alterations in
its biochemical properties. Thus, an alternative explanation is
that disruption of protein function results not from a failure to
be targeted to the hypothetical lipid raft compartment in the
cell but rather from a disruption of important intra- and intermolecular interactions.
Thus, we believe that this report of D2R compartmentalization provides the first definitive evidence for plasma membrane
microcompartment structure that exists within living cells to
restrict the resident molecules from interacting with other
plasma membrane and cytoplasmic proteins. Because D2R is a
major target of drugs used to treat schizophrenia, depression,
and Parkinson disease, our discovery of D2R microcompartmentalization has the potential to alter present assumptions
about the mechanism of action of these drugs.
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